Stefano Ferrari
Founder at Chestnut Hill Sciences LLC
Profile
Stefano Ferrari is the founder of Chestnut Hill Sciences LLC, founded in 2004, where he holds the title of Member.
He was also the founder of Murami Pharma, Inc., founded in 2011, where he held the title of Chief Executive Officer.
Mr. Ferrari's current job(s) include being the Chief Executive Officer & Director at Prime Acquisition, Inc. since 2013, a Director at Matinas BioPharma, Inc. since 2012, and the President of Carigent Therapeutics, Inc.Mr. Ferrari's former job(s) include being the Chief Executive Officer at Bioseutica B.V., an Independent Director at Matinas BioPharma Holdings, Inc. from 2013 to 2018, and a Director at Ikonisys, Inc. He also served as a Director at the Richard B.
Fisher Center for the Performing Arts.
Mr. Ferrari's education history includes completing his undergraduate degree at the University of San Francisco.
Stefano Ferrari active positions
| Companies | Position | Start |
|---|---|---|
Chestnut Hill Sciences LLC
 Chestnut Hill Sciences LLC Miscellaneous Commercial ServicesCommercial Services Chestnut Hill Sciences LLC provides business services. The private company is based in Rhinebeck, NY. The company was founded by Stefano Ferrari. | Founder | 31/12/2003 |
| Matinas BioPharma, Inc. | Director/Board Member | 30/09/2012 |
Prime Acquisition, Inc.
 Prime Acquisition, Inc. Miscellaneous Commercial ServicesCommercial Services Part of NeuBase Therapeutics, Inc., Prime Acquisition, Inc. is an acquisition vehicle. The company is based in Rhinebeck, NY. Stefano Ferrari has been the CEO of the company since 2013. | Chief Executive Officer | 30/09/2013 |
Carigent Therapeutics, Inc.
 Carigent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carigent Therapeutics, Inc. develops pharmaceutical products. The firm delivers drugs and provides development and commercialization of innovative medical treatments. The company was founded by W. Mark Saltzman in January 26, 2007 and is headquartered in New Haven, CT. | President | - |
Former positions of Stefano Ferrari
| Companies | Position | End |
|---|---|---|
| MATINAS BIOPHARMA HOLDINGS, INC. | Director/Board Member | 31/12/2017 |
Bioseutica B.V.
 Bioseutica B.V. Chemicals: Major DiversifiedProcess Industries Bioseutica B.V. manufactures proteins for the food, feed, and pharmaceutical sectors. The private company is based in Lugano, Switzerland, and has subsidiaries in Belgium. | Chief Executive Officer | - |
| Richard B. Fisher Center for the Performing Arts | Director/Board Member | - |
| Murami Pharma, Inc. | Chief Executive Officer | - |
Ikonisys, Inc.
 Ikonisys, Inc. Medical SpecialtiesHealth Technology Ikonisys, Inc. designs and manufactures medical diagnostic products for the diagnosis of cancers. Its products include Ikoniscope Robotic Microscope that provides automated slide handling, slide scanning, real-time image capture and analysis, eliminates various factors that cause human error in testing, oncoFISH bladder that allows scanning and analysis of cells recovered from a voided urine sample. The company was founded by Pramod K. Srivastava, Petros Tsipouras, Gamil G. de Chadarevian, Michael W. Kilpatrick and Triantafyllos Tafas in 1999 and is headquartered in New Haven, CT. | Director/Board Member | - |
Training of Stefano Ferrari
| University of San Francisco | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MATINAS BIOPHARMA HOLDINGS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Carigent Therapeutics, Inc.
Carigent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carigent Therapeutics, Inc. develops pharmaceutical products. The firm delivers drugs and provides development and commercialization of innovative medical treatments. The company was founded by W. Mark Saltzman in January 26, 2007 and is headquartered in New Haven, CT. | Health Technology |
| Matinas BioPharma, Inc. | |
Ikonisys, Inc.
Ikonisys, Inc. Medical SpecialtiesHealth Technology Ikonisys, Inc. designs and manufactures medical diagnostic products for the diagnosis of cancers. Its products include Ikoniscope Robotic Microscope that provides automated slide handling, slide scanning, real-time image capture and analysis, eliminates various factors that cause human error in testing, oncoFISH bladder that allows scanning and analysis of cells recovered from a voided urine sample. The company was founded by Pramod K. Srivastava, Petros Tsipouras, Gamil G. de Chadarevian, Michael W. Kilpatrick and Triantafyllos Tafas in 1999 and is headquartered in New Haven, CT. | Health Technology |
Prime Acquisition, Inc.
Prime Acquisition, Inc. Miscellaneous Commercial ServicesCommercial Services Part of NeuBase Therapeutics, Inc., Prime Acquisition, Inc. is an acquisition vehicle. The company is based in Rhinebeck, NY. Stefano Ferrari has been the CEO of the company since 2013. | Commercial Services |
Bioseutica B.V.
Bioseutica B.V. Chemicals: Major DiversifiedProcess Industries Bioseutica B.V. manufactures proteins for the food, feed, and pharmaceutical sectors. The private company is based in Lugano, Switzerland, and has subsidiaries in Belgium. | Process Industries |
| Richard B. Fisher Center for the Performing Arts | |
Chestnut Hill Sciences LLC
Chestnut Hill Sciences LLC Miscellaneous Commercial ServicesCommercial Services Chestnut Hill Sciences LLC provides business services. The private company is based in Rhinebeck, NY. The company was founded by Stefano Ferrari. | Commercial Services |
| Murami Pharma, Inc. |
- Stock Market
- Insiders
- Stefano Ferrari